Biotech Values

[DewDiligence]

For ABT, a 2011 P/E of 15x would equate to a share price of about $70 (#msg-62372143), so there is plenty of upside if investor fashion changes to allow a company like ABT to sport a valuation commensurate with its slow but steady growth from The Global Demographic Tailwind.